Suzanne E. Davis

The BATTLE trial: personalizing therapy for lung cancer.

Edward S. Kim, S. Lippman, F. Khuri, 2011, Cancer discovery.

Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial

Michael Peyton, John D. Minna, Lixia Diao, 2013, Clinical Cancer Research.

Methodological and practical challenges for personalized cancer therapies

Juri G. Gelovani, Ignacio I. Wistuba, Roy S. Herbst, 2011, Nature Reviews Clinical Oncology.

BATTLE-2 program: A biomarker-integrated targeted therapy study in previously treated patients with advanced non-small cell lung cancer (NSCLC).

K. Coombes, J. Lee, W. Hong, 2013 .

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial

Edward S. Kim, S. Lippman, W. Hong, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel.

Stephen T. C. Wong, Gregory S Fischer, Etay Ziv, 2016, Journal of vascular and interventional radiology : JVIR.

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

P. Hwu, K. Rezvani, E. Shpall, 2018, Nature Reviews Clinical Oncology.

Clinical Outcomes and Biomarker Profiles of Elderly Pretreated NSCLC Patients from the BATTLE Trial

J Jack Lee, Edward S. Kim, Ignacio Wistuba, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Predictive Biomarkers and Personalized Medicine Comprehensive Biomarker Analysis and Final Ef fi cacy Results of Sorafenib in the BATTLE Trial

Edward S. Kim, Jing Wang, J. Minna, 2013 .

Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement

J. Lee, A. Buzdar, G. Wilding, 2017, Clinical Cancer Research.

Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual

K. Hess, J. Lee, A. Buzdar, 2016, Clinical Cancer Research.